Perhaps in an attempt to neutralize me, my comment on Tim Harper's 30 Dec 2011 Científica blog post "The NanoTech Threat from the Developing World"
did not pass his moderating approval
so, was alternatively entered {and subsequently deleted 2 days later from} here:
https://www.facebook.com/CientificaLtd
Such is his prerogative; replicating it here is mine:
"" 0 Responses to The Nanotech Threat from the Developing World
Your comment is awaiting moderation.
Leaving aside for the moment the questionable designation of the term “developing” as to applied to [civilizations] which existed eons before the “developed world” even started suckling on the teats of Enlightenment; ignoring the false dichotomies derived therefrom; and disregarding here the incongruous lumping of continent and nation stats—
That you would cite journal publications of SIG environmentalists deemed to be “fringe” while dismissing reams of extant confirmations of potential and apparently present nanotox assessments conveyed in primary scientific literature -produced from the bench not the lobbying bar- says as much about your myopia (and your [own] decided agenda) as it does about those whom you criticize. All of which is fine; just don’t pretend that you [yourself] don’t have one.
Concerns do exist surrounding particular region-specific patterns of nanotoxicologic and nanopathologic distribution and exposure which differ from those being addressed in the “developed world”, as does interest in the implications of nanotech on federal entities and independent principalities where no guaranteed national health insurance systems are in place to offset future health care provisions for these populations in the event of negative OEHS impact.
Nanotoxicity, nanoneurotoxicity, and nanopathology studies have been conducted in the labs of México, South Africa, Western Asia, India, Thailand, China, and elsewhere. Funding allocations have been sparse.
That you are unaware of this says to me that your next layover should be scheduled in a medical school library.
{PS: I’ve got no pony in this race and hardly do I speak for the NGOs. In fact, my private medical library [division] would be considered anathema to them, existing as it does as an operating unit of a client company [developed out of] Wharton SBDC and my patrons occupy all sides of the ‘scope}. ""
